Change on bioalliance pharma management board

BioAlliance Pharma SA (Euronext Paris – BIO), a company dedicated
to the treatment and supportive care of cancer and AIDS patients, today announced Pierre
Morgon’s departure.
Management Board Member Pierre Morgon joined BioAlliance Pharma in 2008 primarily in
order to supervise the company’s commercial operations in Europe. “As a consequence of
our new organization in Europe with the search of a partner already well established in the
supportive care market, Pierre Morgon has decided to leave the company at the end of this
month (May 2009). We sincerely thank him for his collaboration and his contribution to our
operations management”, said Dominique Costantini, President and CEO of BioAlliance